EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8

Nicole A Hawkins, Nathan Speakes, Jennifer A Kearney iD

Mammalian Genome · 2024-09 · 35 (3) · 334-345

DOI: 10.1007/s00335-024-10046-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mammalian Genome, online erschienen am 11.06.2024. Verfasst von Nicole A Hawkins und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Northwestern University Feinberg School of Medicine, 320 East Superior St., Searle 8-510, Chicago, IL, 60611, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dravet syndrome is a developmental and epileptic encephalopathy (DEE) characterized by intractable seizures, comorbidities related to developmental, cognitive, and motor delays, and a high mortality burden due to sudden unexpected death in epilepsy (SUDEP). Most Dravet syndrome cases are attributed to SCN1A haploinsufficiency, with genetic modifiers and environmental factors influencing disease severity. Mouse models with heterozygous deletion of Scn1a recapitulate key features of Dravet syndrome, including seizures and premature mortality; however, severity varies depending on genetic background. Here, we refined two Dravet survival modifier ( Dsm ) loci, Dsm2 on chromosome 7 and Dsm3 on chromosome 8, using interval-specific congenic (ISC) mapping. Dsm2 was complex and encompassed at least two separate loci, while Dsm3 was refined to a single locus. Candidate modifier genes within these refined loci were prioritized based on brain expression, strain-dependent differences, and biological relevance to seizures or epilepsy. High priority candidate genes for Dsm2 include Nav2 , Ptpn5 , Ldha , Dbx1 , Prmt3 and Slc6a5 , while Dsm3 has a single high priority candidate, Psd3 . This study underscores the complex genetic architecture underlying Dravet syndrome and provides insights into potential modifier genes that could influence disease severity and serve as novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicAnimalsMiceChromosome MappingGenes, ModifierDisease Models, AnimalChromosomes, MammalianNAV1.1 Voltage-Gated Sodium ChannelGenetic Association StudiesQuantitative Trait Loci

Substanzen

NAV1.1 Voltage-Gated Sodium ChannelScn1a protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, Northwestern University Feinberg School of Medicine, 320 East Superior St., Searle 8-510, Chicago, IL, 60611, USA.
  • Department of Pharmacology, Northwestern University Feinberg School of Medicine, 320 East Superior St., Searle 8-510, Chicago, IL, 60611, USA. jennifer.kearney@northwestern.edu.

ORCID-Profile: Jennifer A Kearney

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hawkins, N. A., Speakes, N., & Kearney, J. A. (2024). Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8. Mammalian Genome, 35(3), 334-345. https://doi.org/10.1007/s00335-024-10046-3

Vancouver

Hawkins NA, Speakes N, Kearney JA. Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8. Mammalian Genome. 2024;35(3):334-345. doi:10.1007/s00335-024-10046-3

BibTeX
@article{Hawkins2024,
  author = {Hawkins, Nicole A and Speakes, Nathan and Kearney, Jennifer A},
  title = {Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8},
  journal = {Mammalian Genome},
  year = {2024},
  volume = {35},
  number = {3},
  pages = {334--345},
  doi = {10.1007/s00335-024-10046-3}
}
Kostenlos starten →